| Print Page |
|
Category: Drug Trials
Mon Apr 25, 2011
Dr. Merit Cudkowicz, Principal Investigator for the Ceftriaxone study, will hold an informational web seminar for people with ALS interested in learning more about the clinical trial of Ceftriaxone for ALS on Thursday, May5th, 2011 at 3:00 EST.
Category: Drug Trials
Wed Mar 30, 2011
The Ceftriaxone ALS study is a Phase 3 clinical trial with study sites in 57 locations in Canada and the United States. To see Canadian locations, please visit http://www.als.ca/_news/4432.aspx.
Category: ALS Research
Wed Feb 09, 2011
Dr. Merit Cudkowicz, Principal Investigator for the Ceftriaxone study, will hold an informational web seminar for people with ALS interested in learning more about the clinical trial of Ceftriaxone for ALS. This will be a time to learn about the scientific rationale behind the study, learn about study procedures, and ask questions. Interested people can join the seminar on Wednesday, February 9, 2011 at 2:00 Eastern Standard Time.
Category: Drug Trials
Tue Aug 24, 2010
A clinical study of Ceftriaxone in ALS is currently recruiting participants at 55 locations across Canada and the United States.
Category: General
Fri Jul 30, 2010
ALS Ontario now provides a link to a Payer Access Assistance program through its Resources web page.




